ReCor Medical Revenue and Competitors
Estimated Revenue & Valuation
- ReCor Medical's estimated annual revenue is currently $106.5M per year.
- ReCor Medical's estimated revenue per employee is $351,400
- ReCor Medical's total funding is $15M.
Employee Data
- ReCor Medical has 303 Employees.
- ReCor Medical grew their employee count by 49% last year.
ReCor Medical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
2 | VP General Counsel | Reveal Email/Phone |
3 | Head Intellectual Property Associate General Counsel Senior Director | Reveal Email/Phone |
4 | VP, Regulatory & Medical Affairs | Reveal Email/Phone |
5 | VP Human Resources | Reveal Email/Phone |
6 | VP, Clinical Affairs | Reveal Email/Phone |
7 | VP Operations | Reveal Email/Phone |
8 | Global Senior Director Market Access | Reveal Email/Phone |
9 | Director, Quality Systems and Production | Reveal Email/Phone |
10 | Director Marketing Communications | Reveal Email/Phone |
ReCor Medical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is ReCor Medical?
ReCor Medical is a medical device company that designs and manufactures the Paradise® System, a proprietary ultrasound ablation system for renal denervation (RDN). RDN is a new potential therapeutic approach for the treatment of hypertension, one of the most prevalent medical conditions. The System's intravascular catheters denervate renal nerves by combining the protection of water-based cooling of the renal artery with high intensity ultrasound energy for circumferential renal nerve ablation. The Paradise System has been studied in clinical trials of approximately 300 patients to date. The Paradise System is approved for sale in the EU and bears a CE mark, but is not approved for sale in the United States.
keywords:N/A
$15M
Total Funding
303
Number of Employees
$106.5M
Revenue (est)
49%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ReCor Medical News
... Inc., ReCor Medical, Inc., Renal Dynamics Limited ... Medicare and Medicaid Services report that US healthcare expenditures grew by 4.6%...
Otsuka Medical Devices' subsidiary ReCor Medical has completed subject enrolment in the RADIANCE-II pivotal trial of its Paradise Ultrasound...
ReCor Medical Announces Completion of Enrollment in RADIANCE-II Pivotal Trial of the Paradise Ultrasound Renal Denervation System for the...
Other Companies in Palo Alto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $55.1M | 304 | -16% | N/A |
#2 | $50.5M | 306 | 32% | $2M |
#3 | $53.7M | 307 | 25% | N/A |
#4 | $15M | 312 | N/A | N/A |
#5 | $55.5M | 317 | 14% | $73.2M |